| Financial Year |
March 31 2023 |
| Monetary Funds |
1,628,328,080.52 |
| Held-for-trading Financial Assets |
145,319,013.01 |
| Notes Receivable |
-- |
| Accounts Receivable |
348,421,699.27 |
| Advances to Suppliers |
48,261,557.11 |
| Other Receivables |
21,771,920.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
368,170,513.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
248,992,153.24 |
| Total Current Assets |
3,242,194,755.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,738,752,814.92 |
| Under-construction Projects |
231,459,875.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
218,130,435.19 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
14,886,392.06 |
| Deferred Income Tax Assets |
163,659,937.10 |
| Other Non-Current Assets |
3,507,976.34 |
| Sub-Total of Non-Current Assets |
2,371,054,133.87 |
| Total Assets |
5,613,248,889.61 |
| Short-Term Loans |
1,730,876,846.00 |
| Trading Financial liabilities |
10,099,641.97 |
| Notes Payable |
233,667,913.26 |
| Accounts Payable |
337,156,688.97 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,024,944.22 |
| Taxes Payable |
9,179,016.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
25,043,504.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
560,387,852.44 |
| Other Current Liabilities |
3,486,970.80 |
| Sub-Total of Current Liabilities |
2,940,746,231.67 |
| Long-term Loans |
469,900,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
239,432.49 |
| Special Payable |
-- |
| Estimatied Liabilities |
13,964,739.49 |
| Deferred Income Tax Liabilities |
36,476,296.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
659,590,768.44 |
| Total Liabilities |
3,600,337,000.11 |
| Paid-In Capital(Or Share Stock) |
735,269,837.00 |
| Capital Surplus |
664,191,200.08 |
| Surplus Reserve |
105,876,866.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
506,720,542.80 |
| Minority Stockholder's Interest |
-599,631.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,013,511,521.04 |
| Owner's Equity（Stockholder's Equity） |
2,012,911,889.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,613,248,889.61 |
